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Abstract     
A facile, transition metal free, one-pot oxidative coupling reaction between 6-(hetero)aryl-
[1,2,5]oxadiazolo[3,4-b]pyrazines and pyrroles, indoles or carbazoles is reported. This atom-
economic C-H functionalization procedure requires only stoichiometric amounts of reacting 
heterocycles and an appropriate Lewis acid, as catalyst. The structures of representative new 5,6-
di(hetero)aryl-[1,2,5]oxadiazolo[3,4-b]pyrazines were confirmed by X-ray crystallography. The 
redox and optical measurements for new compounds, bearing carbazole units, have also been 
performed. 
 




Introduction    
 
The C-C cross-coupling reactions of azaaromatic compounds, in particular, of diazines, with 
pyrroles and indoles, are of importance for organic synthesis to prepare new derivatives of this 
family possessing a potential biological activity.1,2 Also, the analogous transformations of diazines 
by action of carbazoles lead to C-C coupling products, demonstrating promising optical and 
electronic properties.3 [1,2,5]Oxadiazolo[3,4-b]pyrazines (furazano[3,4-b]-pyrazines belong to 
one of the important classes of fused diazines.4 Indeed, [1,2,5]-oxadiazolo[3,4-b]-pyrazines have 
attracted considerable attention of chemists, as heat-resistant explosive materials (for example, see 
Figure 1).5  
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Difurazano[3,4-b:3',4'-e]pyrazines [ref. 5c]  
 
Figure 1. Furazano[3,4-b]pyrazines used as heat-resistant explosive materials.  
 
 [1,2,5]Oxadiazolo[3,4-b]pyrazines proved to exhibit a variety of physiological properties, such 
as anticancer,6 anti-HIV,7 and antibacterial activities.8 For this reason the syntheses of 6-
(hetero)aryl-[1,2,5]oxadiazolo[3,4-b]pyrazine - pyrrole (indole or carbazole) hybrid molecules 
appear to be rather interesting for elucidation of their biological, photophysical and 
electrochemical properties. In spite of broad use of furazano[3,4-b]pyrazines, there are only few 
reports in the literature, concerning direct functionalization of this heterocyclic system based on 
nucleophilic aromatic substitution of hydrogen (SNH).9 An enhanced tendency of pyrazines to 
undergo a nucleophilic attack at the unsubstituted carbon of the pyrazine ring has been well 
established.9 For instance, the synthesis of 3-amino-2-(hetero)arylbenzo[b]furans 2 and 5,6-
disubstituted furazano[3,4-b]pyrazines 3 through the reaction of electrophilic furazanopyrazines 1 
with phenols or their methyl ethers in the presence of trifluoroacetic acid, followed by recyclization 
(in case of phenols) or oxidation, has been reported (Scheme 1).10 Also, the addition of ferrocenyl 
lithium or cymantryl lithium at C(6) of furazano[3,4-b]pyrazines 1, followed by oxidation of the 
intermediate σH-adducts, affords the corresponding metallocene derivatives 4 and 5 (Scheme 1).11 
Finally, 6-styryl-5-(hetero)aryl-furazano[3,4-b]pyrazines 6 have been obtained according to the 
same SNH-protocol, by reacting 1 with the corresponding α-nitro-β-arylalkenes.12  
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Scheme 1. The SNH-reactions of [1,2,5]oxadiazolo[3,4-b]pyrazines.  
 
 In this communication we wish to report a convenient synthesis and characterization of novel 
(pyrrol-2-yl)-, (indol-3-yl)- and (9H-carbazol-3-yl)-substituted 5-(hetero)aryl-[1,2,5]-




Results and Discussion  
   
Synthesis 
We have studied the direct C-H functionalization of a number of 5-(hetero)aryl  substituted [1,2,5]-
oxadiazolo[3,4-b]pyrazines 1a-d with pyrroles 7 and 8, indoles 11-13, and carbazoles 17-19 
(Scheme 2). The reactions proved to proceed as a classical nucleophilic aromatic substitution of 
hydrogen (SNH) via the intermediacy of σH-adducts, 5-(hetero)aryl-6-substituted-4,5-dihydro-
[1,2,5]oxadiazolo[3,4-b]pyrazin-4-ium salts, and subsequent oxidation of these dihydro 
compounds by air oxygen (Scheme 3). While some pyrazine derivatives10,13-17 tend to form stable 
crystalline adducts, no intermediate σH-adducts have been isolated from 5-(hetero)aryl-
[1,2,5]oxadiazolo[3,4-b]pyrazines. Since the SNH-reactions usually take place in the presence of 
acidic catalysis, we have tried to use the Lewis acids, such as boron trifluoride diethyl etherate 
(BF3·Et2O), acetic and trifluoroacetic acids. To optimize the reaction conditions a number of 
experiments have been performed, by reacting 5-phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazine (1a) 
with pyrrole (7), indole (11), 1-ethyl-1H-indole (13) and carbazole (17) in the presence of various 
catalysts (Table 1). It has been established that the best yeild of the  SNH-product derived from the 
reaction 1a with pyrroles is reached on using CF3COOH, whereas use of BF3·Et2O and CH3COOH 
leads to a complex multi-component mixture with a large amount of tar. For the SNH reactions with 
indoles all acids proved to be suitable, however application of acetic acid gave the best results 
General Papers  ARKIVOC 2016 (v) 279-300 
 Page 282 ©ARKAT-USA, Inc. 
(yields 71-83%). In contrast, 5-phenyl-[1,2,5]-oxadiazolo[3,4-b]pyrazine (1a) reacts with 
carbazole (17) only in the presence BF3·Et2O, while no SNH-product 20a is observed after 48 hours 
on use of other acidic catalysts (on the basis of TLC data). These facts are in good agreement with 
the decrease in electrophilicity over the series from pyrrole to indole to carbazole with increasing 












































































Method A, B or C9a-d
10a-d













Method A, B or C
Method A: CH3COOH, O2 (air);
Method B: CF3COOH (1 equiv.) in MeCN, O2 (air);
Method C: BF3xEt2O (1 equiv.) in MeCN, O2 (air) 
a: Ar= b: Ar=; c: Ar=; d: Ar=;
 
 
Scheme 2. The SNH reactions of 5-(hetero)aryl-[1,2,5]oxadiazolo[3,4-b]pyrazines with pyrroles,     



























H Adducts S  - ProductsHNHA = Lewis acid  
Scheme 3. A plausible mechanism for the SNH process. 
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Table 1. Optimization of the C-H/C-H coupling 5-phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazine (1a) 
with pyrroles, indoles and carbazoles 
Entry Reaction Conditionsa Time 
(hours) 
Isolated yield (%) 
1 
1a+7 
A 24 30 
2 B 24 47 
3 C 24 n.i. 
4 
1a+11 
A 24 83 
5 B 24 59 
6 C 24 60 
7 
1a+13 
A 24 71 
8 B 24 61 
9 C 24 68 
10 
1a+17 
A 48 n.d. 
11 B 48 n.d. 
12 C 24 59 
n.i.– The  product was not isolated; n.d. – The  product was not detected by TLC.  aMethod A: 
[1]:[Heterocycles]:[CH3COOH] = 1:1:excess (in mmol); Method B: 
[1]:[Heterocycles]:[CF3COOH] = 1:1:1 (in mmol); Method C: [1]:[Heterocycles]:[ BF3·Et2O] = 
1:1:1 (in mmol). 
 
 The optimal conditions, found for the reaction of 5-phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazine 
(1a) with pyrroles, indoles and carbazoles, have been applied for the C-C coupling of 5-
(hetero)aryl-[1,2,5]oxadiazolo[3,4-b]pyrazines (1b-d) with the same nucleophiles. Highly 
electrophilic azines (1a-d) have been found to react smoothly with pyrroles (7,8), indoles (11-13) 
and carbazoles (17-19) at room temperature to give the corresponding products 9-10, 14-16 and 
20-22 in 71% , 87% and 76% yields, respectively. It is worth noting that structures of the SNH-
products 9a, 10d, 14a, 21a, 22a and 22c have been established unequivocally by X-ray 
crystallography (Figs. 2-5, S1 and S2, Table S1, see Supporting Information ). 
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Figure 2. X-ray structure of 10d. 
 
 
 Figure 3. X-ray structure of 14a. 
 
 
 Figure 4. X-ray structure of 21a. 
 
 Figure 5. X-ray structure of 22c. 
 
 Compound 21a is non-planar; the phenyl and carbazole rings are turned towards the pyrazine 
unit with the angles 46o and 39o, correspondingly. As for compound 22c, the tetrameric π-stacked 
“sandwiches” are observed in crystals. Compound 22c is crystallized in the centro-symmetric 
space group. 4-Bromophenyl and N-ethylcarbazole moieties are turned toward the pyrazine ring 
with the angles 43o and 44o, correspondingly. The ethyl substituent in the carbazole ring is turned 
to the side of 4-bromophenyl substituent. In crystals, these molecules form “sandwiches” with π-
π interaction between two furazanopyrazine and two carbazole rings (Fig. 6). In these tetramers 
the nearest C-C distances in π-stacked moieties is 3.212 Å (0.188 Å less then the sum of van der 
Waals radii), and some additional C-C contacts with distances less then 3.3 Å are observed. The 
feature of the crystal packing has to be taken into attention, when considering the spectral data of 
this compound. 
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Figure 6. The tetrameric π-stacked “sandwiches” in the molecular packing for 22c. The interfacial 
distances are also given. Distances are presented in Å. 
 
 Compound 21c is a structural analogue of 22c. However, this compound demonstrates 
significant conformational features. In particular, unlike the compound 22c, the ethyl substituent 
in the carbazole moiety is turned from the plane of 4-bromophenyl substituent. 4-Bromophenyl 
and N-ethyl-substituted carbazole moieties are turned toward the pyrazine ring with the angles 45o 
and 42o, correspondingly. The significantly shortened contacts in the crystal packing of 21c are 
not observed.  
 In the crystals of 9a and 10d the conformations of these molecules are ordered by 
intramolecular H-bonds between NH-group of the pyrrole ring and N-atom of the pyrazine ring. 
As a result, pyrrole and pyrazine fragments proved to form a planar system, and the second 
(hetero)aryl substituent in the  azine ring is turned toward the plane of the pyrazine ring. In 
particular, in the crystals of 10d the phenyl, pyrrole-2-yl and pyrazine moieties are placed in the 
plane with deviations of atoms from this plane in the limits of  0.24 Å. The thien-2-yl substituent 
is turned toward the pyrazine ring with the angle 56o. The crystal packing is characterized by π-π 
interaction between furazano and pyrrole moieties with interatomic distance of 3.35-3.17 Å.   
 The formation of the intramolecular H-bond in 14a is not possible due to a strong sterical 
interaction between the benzene ring of indole and the aryl substituent in the pyrazine ring. As a 
result, only weak intermolecular H-bonds between N-atoms of the pyrazine ring and H-donating 
groups are observed in the crystals. The presence of many intermolecular H-bonds does not permit 
one to assume any efficient π-π-interactions.     
Optical and electrochemical properties 
Organic semiconductors based on carbazole derivatives have extensively been studied as carrier-
transport or host materials for optoelectronic devices, such as photoreceptors, phosphorescent 
organic light-emitting diodes and organic thin-film transistors.19-26 On the basis of these 
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considerations, we have decided to investigate the photophysical and electrochemical properties 
of carbazole-substituted furazano[3,4-b]pyrazines 20a-d and 21a-d. 
UV-vis absorption spectra of 20a-d and 21a-d have been carried out, and the results obtained are 




Figure 7. UV–vis absorption spectra of 20a-d. 
 
Carbazolyl substituted [1,2,5]oxadiazolo[3,4-b]pyrazines show a long-wave absorption band in 
the range of 440-460 nm, which is assigned to the intramolecular charge transfer (ICT) excitation 
from electron-donating fragment (carbazole) to electron acceptor (the pyrazine ring). In general, 
these maxima are shifted bathochromically in the following sequence: 20a (21a), 20c (21c), 20b 
(21b), 20d (21d). The bathochromic shift suggests an introduction of a bromine atom [20c (21c) 
compared with 20c and 21c]. The bathochromic shift implies an increased degree of conjugation, 
resulting from thiophene unit relative to phenyl substituents [20d (21d) compared with 20a-c (21a-
c)] or influence of NO2-group [20b (21b) compared with 20a (21a) and 20c (21c)]. The 
bathochromic shift in the absorption maxima from non-alkylated 20a-d to N-ethyl carbazole 
derivatives 21a-d is attributed to the donor-acceptor character of the molecules 20 and 21 arising 
with addition of the ethyl-group into the carbazole moiety. Compounds 20a-d and 21a-d visual 
exhibited fluorescence in the acetonitrile solution which could not be detected and the fluorescence 
quantum yields of these compounds were below 1.00 % in the solution. 
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For this reason both absorption and fluorescence of [1,2,5]oxadiazolo[3,4-b]pyrazine derivatives 
20a-d and 21a-d in poly(methyl methacrylate) (PMMA) thin film are measured. Relevant 
photophysical data are summarized in Table 2, and excitation and fluorescence spectra of 
[1,2,5]oxadiazolo[3,4-b]pyrazines 20a-d and 21a-d are shown in Figs. S4-S11. The absorption 
maxima of the four dyes 21a-d in the solid state were red-shifted (Table 2) by 2-5 nm compared 
with those for the corresponding dyes in CH3CN. For D-π-A fluorescent dyes, in general, the red-
shifts of absorption or fluorescence maxima by changing from solution to the solid state are quite 
common and explained in terms of the formation of intermolecular π-π interactions27 or continuous 
intermolecular hydrogen bonding28 in the crystalline state leading to delocalization of excitons or 
eximers. 
 The most impressive solid state fluorescence for powder of dyes 20d and 21d under daylight 
and UV irradiation are shown in Figure 8. 
 




Figure 8. Photographs of (1) compound 20d and (2) compound 21d under daylight (top) and under 
UV irradiation (λex   365 nm) (bottom) in the solid state. 
 
  
General Papers  ARKIVOC 2016 (v) 279-300 
 Page 288 ©ARKAT-USA, Inc. 
Table 2. Electrochemical and optical properties of carbazole-substituted [1,2,5]oxadiazolo[3,4-
























20a 0.97 -0.79 -5.69 -3.93 1.76 
441 / 22.43 
333 / 22.06 
320 / 24.59 





20b 0.98 -0.72 -5.70 -4.00 1.70 
450 / 19.70 






20c 0.98 -0.70 -5.70 -4.02 1.68 
445 / 23.14 
335 / 26.40 
321 / 29.18 
283 / 78.18 
236 / 12.81 
- 461 566 
20d 0.97 -0.71 -5.69 -4.01 1.68 
446 / 10.13 
394 / 11.23 
334 / 9.66 
322 / 12.04 
272 / 36.41 




21a 0.90 -0.67 -5.65 -4.02 1.63 
456 / 9.25 
342 / 9.32 
329 / 10.00 
282 / 32.96 




21b 0.93 -0.70 -5.65 -4.02 1.63 
464 / 17.19 




21c 0.93 -0.81 -5.65 -3.91 1.74 
458 / 9.19 
334 / 11.38 
330 / 12.35 
284 / 32.10 
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21d 0.90 -0.70 -5.62 -4.02 1.60 
452 / 7.82 
388 / 9.17 
345 / 9.61 
278 / 31.17 






 In order to determine electrochemical behavior and calculate HOMO–LUMO energy gap of 
any organic compound, cyclic voltammetry (CV) is one of the useful methods. In the cathodic scan 
regime of the cyclic voltammogram of compound 20 and 21, it exhibits one characteristic 
irreversible reduction peak with a onset wave potential (Eredonset) in a range from −0.70 to −0.80 
V, which probably is attributed to furazano moiety reduction (Fig. S12-S19). Similarly, two 
consistent oxidation peaks with onset wave potential in a range from 0.90 to 0.98 V were observed 
for radical anion formation (Fig. S3-S10) emanating from carbazole moiety. The electrochemical 
HOMO–LUMO band gap of all molecules were calculated from the onset potentials of their 
oxidation and reduction peaks and these values are presented in Table 2. 
 This finding suggests that the further tuning of these compounds could lead to very narrow 




Conclusions    
 
The SNH methodology has proven to be an effective approach to modify 6-(hetero)aryl-
[1,2,5]oxadiazolo[3,4-b]pyrazines, derivatives of a highly reactive electron-deficient heterocyclic 
system, through nucleophilic displacement of hydrogen by aromatic C-nucleophiles, such as 
pyrroles, indoles or carbazoles, proceeding via the intermediacy of the C5-adducts. The X-ray 
crystallography data for a number of new 5,6-di(hetero)aryl-[1,2,5]oxadiazolo[3,4-b]pyrazines 
have been presented. 
On a base of the redox and optical studies for derivatives bearing carbazole units it is legitimate to 
say that these compounds can be potentially used for organic electronic applications, but additional 
modifications are required in order to do so. It should be noted that the N-ethyl derivatives 21 and 
22 are more realistic prospects for organic electronic applications than the other products with free 
N-H moieties which are redox liabilities. 
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Experimental Section     
 
General. All reagents and solvents were obtained from commercial sources and dried by using 
standard procedures before use. 5-Phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazine (1a) and 5-(4-
bromophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (1c) were prepared according to the earlier 
reported method.10,29 1H and 13C NMR spectra were recorded on a AVANCE-500 instruments 
using Me4Si as an internal standard. Elemental analysis was carried on a Eurovector EA 3000 
automated analyzer. Melting points were determined on Boetius combined heating stages and were 
not corrected. Flash-column chromatography was carried out using Alfa Aesar silica gel 0.040-
0.063 mm (230–400 mesh), eluting with ethyl acetate-hexane. The progress of reactions and the 
purity of compounds were checked by TLC on Sorbfil plates (Russia), in which the spots were 
visualized with UV light (λ 254 or 365 nm). 
Single crystals were investigated on a Xcalibur E diffractometer on standard procedure (graphite-
monochromated MoK-irradiation, ω-scans with 1o step). Empirical absorption correction vas 
applied. Using SHELXTL, the structures were solved with the ShelXS structure solution program 
by direct methods and refined with the ShelXL refinement package using Least Squares 
minimization in anisotropic approximation for non-hydrogen atoms. The mean crystallographic 
data and results of the refinements are presented in the Table S1. The X-ray crystallography data 
for structures reported in this paper have been deposited with Cambridge Crystallography Data 
Centre as supplementary publications CCDC 1498293 for 9a, CCDC 1498294 for 10d, CCDC 
1498295 for 14a, CCDC 1498296 for 21a, CCDC 1498297 for 21c and CCDC 1498298 for 22c. 
These data can be obtained free of charge from the Cambridge Crystallographic Data Centre  via 
www.ccdc.cam.ac.uk/data_request/cif. 
Cyclic voltammetry was carried out on a Metrohm μAutolab type III potentiostat with a standard 
three-electrode configuration. Typically, a three electrodes cell equipped with a platinum working 
electrode, a Ag/AgNO3 (0.01 M AgNO3 in acetonitrile) reference electrode and a glassy carbon 
rod counter electrode were employed. The measurements were performed in anhydrous CH3CN 
solution containing the present compound (5×10-3 M) and LiClO4 (0.1 M) as the supporting 
electrolyte at a scan rate of 100 mV/s. The potential of reference electrode was calibrated by using 
the ferrocene/ferrocenium redox couple (Fc/Fc+), which has a known oxidation potential of +4.8 
eV.  The electrochemical energy gap was determined as the difference between the onsets of the 
oxidation and the reduction potentials (Egelc = Eoxonset – Eredonset). The HOMO and LUMO energy 
values were estimated from the onset potentials of the first independent oxidation and reduction 
process, respectively. After calibration of the measurements against Fc/Fc+, the HOMO and 
LUMO energy levels were calculated according to the following equations: 
EHOMO (eV) = – [Eoxonset – E1/2(Fc/Fc+) + 4.8] 
ELUMO (eV) = – [Eredonset – E1/2(Fc/Fc+) + 4.8] 
where E1/2(Fc/Fc+) is the half-wave potential of the Fc/Fc+ couple (the oxidation potential of which 
is assumed at 4.8 eV) against the Ag/Ag+ electrode.  
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UV–vis spectra were recorded for a 1×10-5 M acetonitrile solution with Shimadzu UV-2401PC 
spectrophotometer. Fluorescence spectra measurements were performed on a Hitachi F-7000 
fluorescence spectrophotometer at room temperature.  
 
Preparation of polymeric-fluorescent dye thin film. PMMA thin films were prepared as follows: 
20a-d and 21a-d (0.20 mg) was dissolved in 200 μL of a PMMA–CHCl3 solution (10%, w/w). A 
film was obtained by spin coating a 0.2 mL PMMA–CHCl3 solution on quartz glass (size: 2.5 cm 
× 1.2 cm), and dried in air at room temperature. The concentration of 20a-d and 21a-d in PMMA 
thin film is ca 0.1%, 0.2% and 0.4% (w/w). 
 
General procedure for the synthesis of 5-(3-nitrophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine 
(1b) and (5-thien-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (1d). The solution of 3,4-
diaminofurazan (1 g, 10 mmol) and 3-nitrophenylglyoxal [or 2-thienylglyoxal] (10 mmol) in a 
mixture of EtOH (5 mL) and CH3COOH (5 mL) was refluxed for 1 h. After that, the mixture was 
cooled, and the precipitate was filtered and washed with ethanol and then air dried. The desired 
products 1b (or 1d) were obtained as crystalline powders. 
5-(3-Nitrophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (1b). Yield 1.65 g, 68%, yellow powder, 
mp 161-163 °С. δH (500 MHz, DMSO-d6) 9.91 (s, 1H), 9.11 (t, J 1.9 Hz, 1H), 8.87-8.78 (m, 1H), 
8.53 (ddd, J 8.2, 2.2, 0.8 Hz, 1H), 7.97 (t, J 8.0 Hz, 1H); δC (126 MHz, DMSO-d6) 158.1, 155.7, 
152.1, 151.7, 148.4, 135.8, 135.1, 131.0, 127.0, 123.4. Calcd. for C10H5N5O3 (243.18): C 49.03, H 
2.07, N 28.80. Found: C 49.08, H 2.10, N 28.94. 
(5-Thien-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (1d). Yield 1.43 g, 70%, yellow powder, mp 
188 °С. δH (500 MHz, DMSO-d6) 9.77 (s, 1H), 8.55 (d, J 3.7 Hz, 1H), 8.15 (d, J  4.9 Hz, 1H), 
7.47-7.31 (m, 1H); δC (126 MHz, DMSO-d6) 155.1, 154.5, 152.1, 151.5, 140.6, 136.4, 134.7, 
129.8. Calcd. for C8H4N4OS (204.21): C 47.05, H 1.97, N 27.44. Found: C 47.15, H 2.03, N 27.64. 
General procedure for the synthesis of 5-(hetero)aryl-6-(5-R-1H-pyrrol-2-yl)-
[1,2,5]oxadiazolo[3,4-b]pyrazine derivatives (9a-d and 10a-d). To a stirred mixture of 5-
(hetero)aryl-[1,2,5]oxadiazolo[3,4-b]pyrazine (1a, 1b, 1c or 1d) (0.5 mmol) and pyrrole (7) (35 
μL, 0.5 mmol) [or 2-phenyl-1H-pyrrole (8) (72 mg, 0.5 mmol)] in MeCN (4 mL) was added 
CF3COOH (38 μL, 0.5 mmol). The reaction mixture was stirred at room temperature for 24 h. The 
solvent was distilled off in vacuo, and the residual semisolid was washed with aqueous Na2CO3 
and air dried. Purification by flash column chromatography (hexane/ethyl acetate, 1:5) to afford 
the desired SNH-products (9a-d or 10a-d). 
5-Phenyl-6-(1H-pyrrol-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (9a). Yield 62 mg, 47%, bright 
orange powder, mp 194-196 °С. δH (500 MHz, DMSO-d6) 12.38 (s, 1H), 7.67-7.63 (m, 3H), 7.59-
7.55 (m, 2H), 7.20 (t, J 3.1 Hz, 1H), 6.05 (dt, J 4.3, 2.3 Hz, 1H), 5.50-5.38 (m, 1H); δC (126 MHz, 
DMSO-d6) 164.0, 151.8, 151.7, 150.7, 138.4, 130.3, 129.0, 128.6, 128.2, 128.1, 120.0, 111.3. 
Calcd. for C14H9N5O (263.26): C 63.87, H 3.45, N 26.60. Found: C 63.62, H 3.31, N 26.69. 
5-(3-Nitrophenyl)-6-(1H-pyrrol-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (9b). Yield 72 mg, 
47%, bright orange powder, mp 216 °С. δH (500 MHz, DMSO-d6) 12.43 (s, 1H), 8.57-8.55 (m, 
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1H), 8.48 (ddd, J 8.3, 2.3, 0.9 Hz, 1H), 8.14-8.09 (m, 1H), 7.87 (t, J 8.0 Hz, 1H), 7.24-7.18 (m, 
1H), 6.05 (dt, J 4.3, 2.3 Hz, 1H), 5.45 (ddd, J 3.9, 2.5, 1.2 Hz, 1H); δC (126 MHz, DMSO-d6) 
162.1, 151.8, 151.6, 150.7, 147.4, 139.8, 135.3, 130.1, 128.7, 128.2, 125.1, 123.8, 120.0, 111.6. 
Calcd. for C14H8N6O3 (308.26): C 54.55, H 2.62, N 27.26. Found: C 54.30, H 2.50, N 27.25. 
5-(4-Bromophenyl)-6-(1H-pyrrol-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (9c). Yield 74 mg, 
43%, orange powder, mp 217 °С. δH (500 MHz, DMSO-d6) 12.40 (s, 1H), 7.79 (dd, J 8.7, 2.0 Hz, 
2H), 7.63 (dd, J 8.7, 2.1 Hz, 2H), 7.22 (d, J 3.0 Hz, 1H), 6.11 (dt, J 4.3, 2.3 Hz, 1H), 5.55-5.52 (m, 
1H). δC (126 MHz, DMSO-d6) 163.1, 151.7, 151.7, 150.7, 137.6, 131.3, 130.9, 128.8, 128.2, 124.0, 
120.0, 111.4. Calcd. for C14H8BrN5O (342.16): C 49.15, H 2.36, N 20.47. Found: C 49.33, H 2.11, 
N 20.49. 
5-(1H-Pyrrol-2-yl)-(6-thien-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (9d). Yield 61 mg, 45%, 
russet powder, mp 163 °С. δH (500 MHz, DMSO-d6) 12.36 (s, 1H), 7.99 (d, J  4.5 Hz, 1H), 7.63 
(d, J 2.4 Hz, 1H), 7.24 (s, 1H), 7.22-7.15 (m, 1H), 6.26 (s, 1H), 6.16 (s, 1H); δC (126 MHz, DMSO-
d6) 157.1, 152.0, 151.4, 150.7, 139.8, 133.0, 132.5, 128.8, 127.9, 127.6, 119.7, 110.9. Calcd. for 
C12H7N5OS (269.29): C 53.52, H 2.62, N 26.01. Found: C 53.39, H 2.74, N 25.88. 
5-Phenyl-6-(5-phenyl-1H-pyrrol-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (10a). Yield 92 mg, 
54%, orange powder, mp 225 °С. δH (500 MHz, DMSO-d6) 12.47 (s, 1H), 7.96 (d, J 7.4 Hz, 2H), 
7.71-7.63 (m, 3H), 7.58 (t, J 7.4 Hz, 2H), 7.42 (t, J 7.5 Hz, 2H), 7.34 (t, J 7.3 Hz, 1H), 6.58 (d, J 
2.4 Hz, 1H), 5.56 (d, J 3.0 Hz, 1H); δC (126 MHz, DMSO-d6) 164.1, 151.7, 151.3, 150.7, 140.7, 
138.5, 130.8, 130.44, 130.37, 128.8, 128.7, 128.3, 126.0, 121.8, 110.1. Calcd. for C20H13N5O 
(339.36): C 70.79, H 3.86, N 20.64. Found: C 70.34, H 3.77, N 20.39. 
5-(3-Nitrophenyl)-6-(5-phenyl-1H-pyrrol-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (10b). Yield 
136 mg, 71%, red powder, mp 236 °С. δH (500 MHz, DMSO-d6) 12.55 (s, 1H), 8.61 (d, J 1.5 Hz, 
1H), 8.51 (dd, J 8.3, 1.3 Hz, 1H), 8.16 (d, J 7.7 Hz, 1H), 7.97 (d, J 7.7 Hz, 2H), 7.89 (t, J 8.0 Hz, 
1H), 7.43 (t, J 7.5 Hz, 2H), 7.34 (t, J 7.3 Hz, 1H), 6.60 (dd, J 4.1, 2.5 Hz, 1H), 5.60 (dd, J 4.0, 2.3 
Hz, 1H); δC (126 MHz, DMSO-d6) 162.3, 151.8, 151.0, 150.7, 147.5, 140.9, 139.9, 135.4, 130.4, 
130.3, 130.1, 128.7, 128.3, 126.0, 125.2, 123.9, 121.9, 110.3. Calcd. for C20H12N6O3 (384.36): C 
62.50, H 3.15, N 21.87. Found: C 62.71, H 3.03, N 21.63. 
5-(4-Bromophenyl)-6-(5-phenyl-1H-pyrrol-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (10c). 
Yield 132 mg, 63%, red powder, mp 257 °С. δH (500 MHz, DMSO-d6) 12.50 (s, 1H), 7.96 (d, J 
7.5 Hz, 2H), 7.80 (d, J 8.4 Hz, 2H), 7.67 (d, J 8.4 Hz, 2H), 7.43 (t, J 7.5 Hz, 2H), 7.34 (t, J 7.3 Hz, 
1H), 6.64 (dd, J 4.0, 1.9 Hz, 1H), 5.66 (dd, J 4.0, 1.6 Hz, 1H). δC (126 MHz, DMSO-d6) 163.2, 
151.7, 151.1, 150.7, 140.8, 137.7, 131.4, 131.0, 130.6, 130.4, 128.7, 128.3, 126.0, 124.1, 121.8, 
110.2. Calcd. for C20H12BrN5O (418.26): C 57.43, H 2.89, N 16.74. Found: C 57.23, H 3.04, N 
16.48. 
5-(5-Phenyl-1H-pyrrol-2-yl)-(6-thien-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (10d). Yield 116 
mg, 67%, dark red powder, mp 244 °С. δH (500 MHz, DMSO-d6) 12.54 (s, 1H), 8.03 (dd, J 5.0, 
1.1 Hz, 1H), 8.01-7.94 (m, 2H), 7.70 (dd, J 3.8, 1.1 Hz, 1H), 7.45 (dd, J 10.6, 4.8 Hz, 2H), 7.34 
(dd, J 11.5, 4.1 Hz, 1H), 7.21 (dd, J 5.0, 3.8 Hz, 1H), 6.72 (dd, J 4.1, 2.5 Hz, 1H), 6.42 (dd, J 4.1, 
2.2 Hz, 1H); δC (126 MHz, DMSO-d6) 157.2, 151.4, 151.4, 150.8, 140.5, 140.1, 133.26, 132.9, 
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130.5, 130.5, 128.8, 128.2, 127.7, 125.8, 121.5, 109.6. Calcd. for C18H11N5OS (345.39): C 62.60, 
H 3.21, N 20.28. Found: C 62.42, H 3.30, N 20.14. 
General procedure for the synthesis of 6-(hetero)aryl-5-(1H-indol-3-yl)-[1,2,5]oxadiazolo-
[3,4-b]pyrazine (14a-d), 6-(hetero)aryl-5-(2-methyl-1H-indol-3-yl)-[1,2,5]oxadiazolo[3,4-b]-
pyrazine (15a-d) and 6-(hetero)aryl-5-(1-ethyl-1H-indol-3-yl)-[1,2,5]oxadiazolo[3,4-b]-
pyrazine (16a-d) derivatives. To a stirred solution of 5-(hetero)aryl-[1,2,5]oxadiazolo[3,4-
b]pyrazine (1a, 1b, 1c or 1d) (0.5 mmol) in CH3COOH (5 mL) was added indole (11) (59 mg, 0.5 
mmol) [2-methyl-1H-indole (12) (66 mg, 0.5 mmol) or 1-ethyl-1H-indole (13) (73 mg, 0.5 mmol)]. 
The reaction mixture was stirred at room temperature for 24 h. The solvent was removed in vacuo, 
and the residual semisolid was washed with aqueous Na2CO3 and air dried. The residue was 
recrystallized from isopropyl alcohol or methanol to afford the desired SNH-products (14a-d, 15a-
d or 16a-d). 
5-(1H-Indol-3-yl)-6-phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazine (14a). Yield 130 mg, 83%, dark 
red powder, mp 128-130 °С. δH (500 MHz, DMSO-d6) 11.91 (s, 1H), 8.61-8.57 (m, 1H), 7.71-7.62 
(m, 3H), 7.56 (t, J 7.5 Hz, 2H), 7.46 (dd, J 5.8, 3.0 Hz, 1H), 7.34-7.23 (m, 2H), 6.59 (d, J  3.2 Hz, 
1H); δC (126 MHz, DMSO-d6) 164.7, 157.9, 151.9, 150.3, 138.9, 136.3, 134.2, 130.5, 129.0, 128.4, 
126.2, 123.7, 122.7, 122.2, 113.5, 112.4. Calcd. for C18H11N5O (313.32): C 69.00, H 3.54, N 22.35. 
Found: C 69.22, H 3.63, N 22.51. 
5-(1H-Indol-3-yl)-6-(3-nitrophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (14b). Yield 142 mg, 
79%, orange powder, mp 279 °С. δH (500 MHz, DMSO-d6) 11.85 (s, 1H), 8.60-8.58 (m, 1H), 8.57-
8.54 (m, 1H), 8.48 (ddd, J 8.3, 2.3, 0.9 Hz, 1H), 8.14-8.04 (m, 1H), 7.82 (t, J 8.0 Hz, 1H), 7.54-
7.42 (m, 1H), 7.39-7.24 (m, 2H), 6.81 (d, J 2.7 Hz, 1H); δC (126 MHz, DMSO-d6) 162.9, 157.6, 
152.0, 150.3, 147.7, 140.2, 136.4, 135.7, 134.6, 130.0, 126.1, 125.2, 124.2, 123.8, 122.5, 122.2, 
113.2, 112.5. Calcd. for C18H10N6O3 (358.32): C 60.34, H 2.81, N 23.45. Found: C 60.17, H 2.92, 
N 23.17. 
5-(4-Bromophenyl)-6-(1H-indol-3-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (14с). Yield 171 mg, 
87%, red powder, mp 309-310 °С. δH (500 MHz, DMSO-d6) 11.91 (s, 1H), 8.60-8.51 (m, 1H), 
7.77 (d, J 8.4 Hz, 2H), 7.63 (d, J 8.4 Hz, 2H), 7.52-7.44 (m, 1H), 7.33- 7.24 (m, 2H), 6.76 (s, 1H); 
δC (126 MHz, DMSO-d6) 163.8, 157.7, 151.9, 150.3, 138.0, 136.3, 134.3, 131.5, 131.3, 126.1, 
124.2, 123.7, 122.5, 122.1, 113.3, 112.5. Calcd. for C18H10BrN5O (392.22): C 55.12, H 2.57, N 
17.86. Found: C 54.91, H 2.54, N 17.77. 
5-(1H-Indol-3-yl)-(6-thien-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (14d). Yield 125 mg, 78%, 
dark red powder, mp 258 °С. δH (500 MHz, DMSO-d6) 12.02 (s, 1H), 8.24 (d, J 7.6 Hz, 1H), 7.98 
(dd, J 5.0, 0.7 Hz, 1H), 7.57 (d, J 3.1 Hz, 1H), 7.55-7.47 (m, 2H), 7.32-7.17 (m, 2H), 7.11 (dd, J 
4.8, 4.0 Hz, 1H); δC (126 MHz, DMSO-d6) 157.82, 157.77, 151.6, 150.6, 141.0, 136.5, 133.7, 
133.4, 133.3, 127.9, 126.0, 123.4, 121.9, 121.8, 113.5, 112.5. Calcd. for C16H9N5OS (319.35): C 
60.18, H 2.84, N 21.93. Found: C 59.99, H 2.76, N 21.74. 
5-(2-Methyl-1H-indol-3-yl)-6-phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazine (15a). Yield 113 mg, 
69%, dark red powder, mp 237 °С. δH (500 MHz, DMSO-d6) 11.69 (s, 1H), 7.65-7.53 (m, 2H), 
7.42 (dd, J 13.7, 7.6 Hz, 2H), 7.35-7.27 (m, 3H), 7.11-7.00 (m, 1H), 6.96-6.86 (m, 1H), 2.08 (s, 
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3H); δC (126 MHz, DMSO-d6) 164.1, 159.6, 151.7, 151.2, 140.2, 138.1, 135.2, 130.5, 129.5, 127.9, 
126.9, 121.6, 120.2, 119.5, 111.6, 111.0, 12.9. Calcd. for C19H13N5O (327.35): C 69.72, H 4.00, N 
21.39. Found: C 69.67, H 3.93, N 21.51. 
5-(2-Methyl-1H-indol-3-yl)-6-(3-nitrophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (15b). Yield 
102 mg, 55%, dark red powder, mp 251 °С. δH (500 MHz, DMSO-d6) 11.79 (s, 1H), 8.38 (t, J 1.8 
Hz, 1H), 8.21 (dd, J 8.1, 2.1 Hz, 1H), 7.94 (d, J 7.8 Hz, 1H), 7.55 (t, J 8.0 Hz, 1H), 7.28 (d, J 8.1 
Hz, 1H), 7.17 (d, J 8.0 Hz, 1H), 6.99 (t, J 7.5 Hz, 1H), 6.80 (t, J 7.5 Hz, 1H), 2.28 (s, 3H); δC (126 
MHz, DMSO-d6) 162.4, 159.3, 151.9, 151.2, 147.0, 140.7, 139.4, 135.7, 135.2, 129.5, 126.3, 
124.9, 124.3, 121.7, 120.2, 119.3, 111.1, 110.9, 12.9. Calcd. for C19H12N6O3 (372.35): C 61.29, H 
3.25, N 22.57. Found: C 61.24, H 3.24, N 22.61. 
5-(4-Bromophenyl)-6-(2-methyl-1H-indol-3-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (15с). Yield 
140 mg, 69%, dark red powder, mp 142 °С. δH (500 MHz, DMSO-d6) 11.74 (s, 1H), 7.61-7.45 (m, 
4H), 7.33 (t, J 7.6 Hz, 2H), 7.06 (t, J 7.6 Hz, 1H), 6.91 (t, J 7.9 Hz, 1H), 2.17 (s, 3H); δC (126 
MHz, DMSO-d6) 163.3, 159.4, 151.8, 151.2, 140.3, 137.3, 135.2, 131.4, 131.0, 126.7, 124.4, 
121.7, 120.2, 119.4, 111.4, 111.1, 13.0. Calcd. for C19H12BrN5O (406.24): C 56.18, H 2.98, N 
17.24. Found: C 56.12, H 2.97, N 17.19. 
5-(2-Methyl-1H-indol-3-yl)-(6-thien-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (15d). Yield 70 
mg, 42%, dark red powder, mp 251 °С. δH (500 MHz, DMSO-d6) 11.83 (s, 1H), 7.88 (d, J 4.8 Hz, 
1H), 7.36 (dd, J 16.1, 8.1 Hz, 2H), 7.18 (d, J 3.6 Hz, 1H), 7.09 (t, J 7.5 Hz, 1H), 6.95 (dd, J 8.6, 
6.1 Hz, 2H), 2.29 (s, 3H); δC (126 MHz, DMSO-d6) 158.9, 156.9, 151.5, 151.1, 141.1, 140.0, 
135.2, 134.3, 133.3, 128.4, 127.1, 121.7, 120.3, 119.3, 111.3, 111.2, 12.8. Calcd. for C17H11N5OS 
(333.37): C 61.25, H 3.33, N 21.01. Found: C 61.18, H 3.29, N 21.09. 
5-(1-Ethyl-1H-indol-3-yl)-6-phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazine (16a). Yield 116 mg, 
68%, orange powder, mp 216 °С. δH (500 MHz, DMSO-d6) 8.59 (dt, J 7.2, 3.2 Hz, 1H), 7.71-7.64 
(m, 3H), 7.63-7.55 (m, 3H), 7.39-7.29 (m, 2H), 6.60 (s, 1H), 4.04 (q, J 7.2 Hz, 2H), 1.13 (t, J 7.2 
Hz, 3H); δC (126 MHz, DMSO-d6) 164.8, 157.6, 151.9, 150.4, 138.8, 136.1, 135.9, 130.5, 129.1, 
128.4, 126.7, 123.7, 122.8, 122.5, 112.6, 110.9, 40.9, 14.7. Calcd. for C20H15N5O (341.38): C 
70.37, H 4.43, N 20.52. Found: C 70.12, H 4.37, N 20.48. 
5-(1-Ethyl-1H-indol-3-yl)-6-(3-nitrophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (16b). Yield 99 
mg, 51%, orange powder, mp 245 °С. δH (500 MHz, DMSO-d6) 8.64-8.53 (m, 2H), 8.53-8.44 (m, 
1H), 8.07 (dd, J 8.9, 1.1 Hz, 1H), 7.81 (t, J 8.0 Hz, 1H), 7.67-7.53 (m, 1H), 7.40-7.25 (m, 2H), 
6.85 (s, 1H), 4.09 (q, J 7.1 Hz, 2H), 1.12 (t, J 7.2 Hz, 3H); δC (126 MHz, DMSO-d6) 162.9, 157.3, 
152.0, 150.4, 147.7, 139.9, 136.3, 136.0, 135.8, 129.9, 126.7, 125.3, 124.3, 123.8, 122.7, 122.5, 
112.3, 110.9, 40.9, 15.1. Calcd. for C20H14N6O3 (386.37): C 62.17, H 3.65, N 21.75. Found: C 
62.24, H 3.77, N 21.65. 
5-(4-Bromophenyl)-6-(1-ethyl-1H-indol-3-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (16с). Yield 
92 mg, 44%, orange powder, mp 238 °С. δH (500 MHz, DMSO-d6) 8.55-8.51 (m, 1H), 7.77 (d, J 
8.4 Hz, 2H), 7.66-7.59 (m, 3H), 7.37-7.31 (m, 2H), 6.79 (s, 1H), 4.11 (q, J 7.2 Hz, 2H), 1.18 (t, J 
7.2 Hz, 3H); δC (126 MHz, DMSO-d6) 163.9, 157.4, 151.9, 150.4, 137.8, 136.1, 135.9, 131.4, 
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131.4, 126.6, 124.3, 123.7, 122.6, 122.5, 112.5, 110.9, 40.9, 14.8. Calcd. for C20H14BrN5O 
(420.27): C 57.16, H 3.36, N 16.66. Found: C 57.14, H 3.34, N 16.84. 
5-(1-Ethyl-1H-indol-3-yl)-(6-thien-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazine (16d). Yield 125 
mg, 72%, orange, mp 237 °С. δH (500 MHz, DMSO-d6) 8.23 (d, J 7.8 Hz, 1H), 8.01 (d, J 4.8 Hz, 
1H), 7.68 (s, 1H), 7.65 (d, J 8.1 Hz, 1H), 7.53 (d, J 3.4 Hz, 1H), 7.33 (t, J 7.5 Hz, 1H), 7.28 (t, J 
7.4 Hz, 1H), 7.13 (t, J 4.3 Hz, 1H), 4.23 (q, J 7.2 Hz, 2H), 1.31 (t, J 7.2 Hz, 3H); δC (126 MHz, 
DMSO-d6) 157.7, 157.4, 151.5, 150.6, 140.9, 136.1, 135.7, 133.6, 133.5, 127.9, 126.5, 123.4, 
122.1, 112.6, 111.0, 110.9, 41.0, 15.2. Calcd. for C18H13N5OS (347.40): C 62.23, H 3.77, N 20.16. 
Found: C 62.14, H 3.81, N 20.19. 
 
General procedure for the synthesis of 3-[6-(hetero)aryl-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-
yl]-9H-carbazole (20a-d), 9-ethyl-3-[6-phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]-9H-
carbazole (21a-d) and 3-bromo-9-ethyl-3-[6-(hetero)aryl-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-
yl]-9H-carbazole (22a-d) derivatives. To a stirred mixture of 5-(hetero)aryl-
[1,2,5]oxadiazolo[3,4-b]pyrazine (1a, 1b, 1c or 1d) (0.5 mmol) and carbazole (17) (0.5 mmol) [9-
ethyl-9H-carbazole (18) or 3-bromo-9-ethyl-9H-carbazole (18)] in MeCN (4 mL) was added 
BF3·Et2O (62 μL, 0.5 mmol). The solvent was removed in vacuo, and the residual semisolid was 
washed with aqueous Na2CO3 and air dried. The residue was recrystallized from isopropyl alcohol 
to afford the desired SNH-products (20a-d, 21a-d or 22a-d). 
3-(6-Phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)-9H-carbazole (20a). Yield 107 mg, 59%, 
red powder, mp 296 °С. δH (500 MHz, DMSO-d6) 11.63 (s, 1H), 8.34 (s, 1H), 8.00 (d, J 7.7 Hz, 
1H), 7.54-7.35 (m, 9H), 7.20 (t, J 7.5 Hz, 1H); δC (126 MHz, DMSO-d6) 163.2, 162.8, 150.6, 
150.2, 139.9, 139.1, 137.1, 129.3, 128.6, 127.0, 126.9, 126.4, 125.2, 122.0, 121.2, 120.9, 119.0, 
118.4, 110.3, 109.1. Calcd. for C22H13N5O (363.38): C 72.72, H 3.61, N 19.27. Found: C 72.58, H 
3.57, N 19.35. 
3-[6-(3-Nitrophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]-9H-carbazole (20b). Yield 116 
mg, 57%, red powder, mp 285 °С. δH (500 MHz, DMSO-d6) 11.62 (s, 1H), 8.40 (d, J 9.9 Hz, 2H), 
8.31 (dd, J 8.2, 1.4 Hz, 1H), 8.06 (d, J 7.8 Hz, 1H), 7.83 (d, J 7.9 Hz, 1H), 7.62 (t, J 8.0 Hz, 1H), 
7.51 (d, J 8.1 Hz, 1H), 7.45-7.37 (m, 3H), 7.18 (t, J 7.4 Hz, 1H); δC (126 MHz, DMSO-d6) 162.6, 
161.5, 150.7, 150.2, 146.1, 140.0, 139.1, 138.5, 135.0, 128.5, 127.1, 125.7, 125.3, 123.8, 123.5, 
122.3, 121.12, 121.07, 119.2, 118.4, 110.3, 109.3. Calcd. for C22H12N6O3 (408.38): C 64.71, H 
2.96, N 20.58. Found: C 64.74, H 2.94, N 20.60. 
3-[6-(4-Bromophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]-9H-carbazole (20c). Yield 168 
mg, 76%, orange powder, mp 302 °С. δH (500 MHz, DMSO-d6) 11.65 (s, 1H), 8.40 (s, 1H), 8.07 
(d, J 7.8 Hz, 1H), 7.61 (d, J 8.5 Hz, 2H), 7.54 (d, J 8.1 Hz, 1H), 7.48-7.41 (m, 4H), 7.38 (dd, J 8.5, 
1.7 Hz, 1H), 7.22 (t, J 7.3 Hz, 1H); δC (126 MHz, DMSO-d6) 163.8, 163.4, 151.7, 151.3, 141.1, 
140.3, 137.3, 131.8, 131.1, 128.1, 127.3, 126.3, 124.3, 123.1, 122.3, 122.2, 120.2, 119.5, 111.5, 
110.3. Calcd. for C22H12BrN5O (442.28): C 59.75, H 2.73, N 15.83. Found: C 59.65, H 2.69, N 
15.81. 
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3-(6-Thien-2-yl-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)-9H-carbazole (20d). Yield 150 mg, 
68%, orange powder, mp 302 °С. δH (500 MHz, DMSO-d6) 11.69 (s, 1H), 8.51 (d, J 1.4 Hz, 1H), 
8.15 (d, J 7.8 Hz, 1H), 7.93 (dd, J 5.0, 0.9 Hz, 1H), 7.64 (dd, J 8.4, 1.7 Hz, 1H), 7.58 (dd, J 8.1, 
6.3 Hz, 2H), 7.50-7.43 (m, 1H), 7.22 (t, J 7.5 Hz, 1H), 6.96 (dd, J 4.9, 4.1 Hz, 1H), 6.81 (dd, J 3.9, 
0.9 Hz, 1H); δC (126 MHz, DMSO-d6) 163.9, 156.6, 151.3, 151.2, 141.5, 141.1, 140.3, 134.6, 
134.4, 128.4, 127.9, 127.3, 126.4, 122.3, 122.1, 122.1, 120.5, 119.4, 111.4, 110.5. Calcd. for 
C20H11N5OS (369.41): C 65.03, H 3.00, N 18.96. Found: C 64.94, H 3.12, N 18.82. 
9-Ethyl-3-(6-phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)-9H-carbazole (21a). Yield 86 mg, 
44%, dark red powder, mp 177 °С. δH (500 MHz, DMSO-d6) 8.35 (d, J 1.6 Hz, 1H), 8.02 (d, J 7.7 
Hz, 1H), 7.62 (d, J 8.2 Hz, 1H), 7.55-7.43 (m, 6H), 7.35 (t, J 7.7 Hz, 2H), 7.21 (t, J 7.3 Hz, 1H), 
4.41 (q, J 7.1 Hz, 2H), 1.28 (t, J 7.1 Hz, 3H); δC (126 MHz, DMSO-d6) 164.3, 163.7, 151.7, 151.3, 
140.8, 140.1, 138.2, 130.4, 129.7, 128.2, 128.0, 127.7, 126.4, 123.2, 122.1, 121.7, 120.3, 119.7, 
109.7, 108.4, 37.2, 13.7. Calcd. for C24H17N5O (391.44): C 73.64, H 4.38, N 17.89. Found: C 
73.54, H 4.34, N 17.83. 
9-Ethyl-3-[6-(3-nitrophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]-9H-carbazole (21b). Yield 
131 mg, 60%, dark red powder, mp 167 °С. δH (500 MHz, DMSO-d6) 8.43 (s, 2H), 8.33 (dd, J 8.1, 
2.0 Hz, 1H), 8.12 (d, J 7.5 Hz, 1H), 7.86 (d, J 7.8 Hz, 1H), 7.65 (dd, J 16.0, 8.0 Hz, 2H), 7.57 (d, 
J 8.8 Hz, 1H), 7.54-7.44 (m, 2H), 7.25 (t, J 7.5 Hz, 1H), 4.45 (q, J 7.1 Hz, 2H), 1.30 (t, J 7.1 Hz, 
3H); δC (126 MHz, DMSO-d6) 163.6, 162.6, 151.8, 151.3, 147.3, 140.8, 140.1, 139.5, 136.2, 129.6, 
128.4, 127.0, 126.6, 124.9, 124.7, 123.4, 122.1, 121.9, 120.5, 119.8, 109.7, 108.6, 37.2, 13.6. 
Calcd. for C24H16N6O3 (436.43): C 66.05, H 3.70, N 19.26. Found: C 66.14, H 3.84, N 19.35. 
3-[6-(4-Bromophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]-9-ethyl-9H-carbazole (21c). 
Yield 125 mg, 53%, dark red powder, mp 281 °С. δH (500 MHz, DMSO-d6) 8.42 (d, J 1.5 Hz, 1H), 
8.10 (d, J 7.8 Hz, 1H), 7.68 (d, J 8.2 Hz, 1H), 7.61 (dd, J 8.6, 3.3 Hz, 3H), 7.52 (t, J 7.6 Hz, 1H), 
7.47 (d, J 8.5 Hz, 3H), 7.26 (t, J 7.5 Hz, 1H), 4.47 (q, J 7.1 Hz, 2H), 1.32 (t, J 7.1 Hz, 2H); δC (126 
MHz, DMSO-d6) 163.7, 163.5, 151.7, 151.3, 140.8, 140.1, 137.4, 131.8, 131.1, 128.2, 127.5, 
126.5, 124.3, 123.2, 122.1, 121.9, 120.4, 119.8, 109.7, 108.6, 37.2, 13.7. Calcd. for C24H16BrN5O 
(470.33): C 61.29, H 3.43, N 14.89. Found: C 61.24, H 3.47, N 14.86. 
9-Ethyl-3-(6-thien-2-yl-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)-9H-carbazole (21d). Yield 111 
mg, 56%, dark red powder, mp 163 °С. δH (500 MHz, DMSO-d6) 8.55 (d, J 1.4 Hz, 1H), 8.20 (d, 
J 7.7 Hz, 1H), 7.93 (dd, J 5.0, 1.0 Hz, 1H), 7.77-7.68 (m, 3H), 7.56-7.51 (m, 1H), 7.26 (t, J 7.4 
Hz, 1H), 6.96 (dd, J 4.9, 4.0 Hz, 1H), 6.83 (dd, J 3.9, 1.0 Hz, 1H), 4.53 (q, J 7.1 Hz, 2H), 1.38 (t, 
J 7.1 Hz, 3H); δC (126 MHz, DMSO-d6) 163.8, 156.6, 151.3, 151.2, 141.5, 140.8, 140.2, 134.6, 
134.4, 128.4, 128.1, 127.4, 126.5, 122.2, 122.1, 121.8, 120.7, 119.7, 109.7, 108.7, 37.3, 13.7. 
Calcd. for C22H15N5OS (397.46): C 66.48, H 3.80, N 17.62. Found: C 66.64, H 3.94, N 17.59. 
3-Bromo-9-ethyl-3-(6-phenyl-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)-9H-carbazole (22a). 
Yield 87 mg, 37%, dark red powder, mp 222 °С. δH (500 MHz, DMSO-d6) 8.46 (d, J 1.4 Hz, 1H), 
8.31 (d, J 1.6 Hz, 1H), 7.64 (d, J 8.7 Hz, 1H), 7.60 (dd, J 8.7, 1.4 Hz, 1H), 7.55 (d, J 8.7 Hz, 1H), 
7.52-7.43 (m, 4H), 7.37 (t, J 7.7 Hz, 2H), 4.42 (q, J 7.0 Hz, 2H), 1.27 (t, J 7.1 Hz, 3H); δC (126 
MHz, DMSO-d6) 164.2, 163.6, 151.7, 151.4, 141.1, 138.9, 138.0, 130.5, 129.8, 128.9, 128.8, 
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128.3, 128.1, 124.0, 123.7, 123.0, 120.8, 111.9, 111.8, 108.7, 37.4, 13.6. Calcd. for C24H16BrN5O 
(470.33): C 61.29, H 3.43, N 14.89. Found: C 61.24, H 3.44, N 14.79. 
3-Bromo-9-ethyl-3-[6-(3-nitrophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]-9H-carbazole 
(22b). Yield 88 mg, 34%, dark red powder, mp 275 °С. δH (500 MHz, DMSO-d6) 8.54 (d, J 1.6 
Hz, 1H), 8.44 (d, J 1.7 Hz, 1H), 8.41 (t, J 2.0 Hz, 1H), 8.34 (dd, J 8.0, 2.4 Hz, 1H), 7.85 (d, J 7.8 
Hz, 1H), 7.69-7.62 (m, 3H), 7.59 (d, J 8.7 Hz, 1H), 7.47 (dd, J 8.7, 1.7 Hz, 1H), 4.45 (q, J 7.1 Hz, 
2H), 1.28 (t, J 7.1 Hz, 3H); δC (126 MHz, DMSO-d6) 163.5, 162.5, 151.8, 151.3, 147.3, 141.1, 
139.4, 138.9, 136.2, 129.6, 129.0, 128.9, 127.6, 125.0, 124.7, 124.03, 123.98, 123.3, 121.0, 112.0, 
111.8, 108.9, 37.4, 13.6. Calcd. for C24H15BrN6O3 (515.33): C 55.94, H 2.93, N 16.31. Found: C 
55.72, H 2.94, N 16.22. 
3-Bromo-6-[6-(4-Bromophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]-9-ethyl-9H-carbazole 
(22c). Yield 85 mg, 31%, dark red powder, mp 217 °С. δH (500 MHz, DMSO-d6) 8.53 (d, J 1.5 
Hz, 1H), 8.41 (d, J 1.6 Hz, 1H), 7.69-7.60 (m, 5H), 7.47-7.44 (m, 3H), 4.46 (q, J 7.1 Hz, 2H), 1.30 
(t, J 7.1 Hz, 3H); δC (126 MHz, DMSO-d6) 163.5, 163.3, 151.7, 151.3, 141.1, 138.9, 137.2, 131.9, 
131.1, 128.9, 128.0, 124.3, 124.1, 123.7, 123.1, 120.9, 111.9, 111.8, 108.8, 37.4, 13.6. Calcd. for 
C24H15Br2N5O (549.23): C 52.49, H 2.75, N 12.75. Found: C 52.34, H 2.84, N 12.68. 
3-Bromo-9-ethyl-3-(6-thien-2-yl-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)-9H-carbazole (22d). 
Yield 83 mg, 35%, orange powder, mp 226 °С. δH (500 MHz, DMSO-d6) 8.61 (d, J 1.0 Hz, 1H), 
8.46 (d, J 1.8 Hz, 1H), 7.92 (dd, J 5.0, 0.9 Hz, 1H), 7.71 (dt, J 8.6, 5.1 Hz, 2H), 7.66 (d, J 8.7 Hz, 
1H), 7.61 (dd, J 8.7, 1.9 Hz, 1H), 6.94 (dd, J 4.9, 4.0 Hz, 1H), 6.78 (dd, J 3.9, 0.9 Hz, 1H), 4.48 
(q, J 7.1 Hz, 2H), 1.33 (t, J 7.1 Hz, 3H); δC (126 MHz, DMSO-d6) 163.5, 156.4, 151.3, 151.1, 
141.4, 141.1, 138.9, 134.7, 134.4, 128.9, 128.6, 128.4, 128.3, 124.0, 123.3, 122.7, 120.9, 111.8, 
111.7, 109.1, 37.5, 13.7. Calcd. for C22H14BrN5OS (476.36): C 55.47, H 2.96, N 14.70. Found: C 
55.32, H 2.94, N 14.59. 
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